New drugs to treat irritable bowel syndrome being tested.
D001572:Benzofurans / Q000627:therapeutic use; D002243:Carbolines / Q000627:therapeutic use*; D003109:Colonic Diseases, Functional / Q000188:drug therapy*; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D008297:Male; D012702:Serotonin Antagonists / Q000627:therapeutic use*
D001572:Benzofurans; D002243:Carbolines; D005765:Gastrointestinal Agents; D006146:Guanidines; D007211:Indoles; D012702:Serotonin Antagonists; C406662:prucalopride; C090840:alosetron; C105050:tegaserod